Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Axogen (AXGN) Net Income towards Common Stockholders (2016 - 2026)

Axogen has reported Net Income towards Common Stockholders over the past 17 years, most recently at -$2.8 million for Q1 2026.

  • For Q1 2026, Net Income towards Common Stockholders rose 24.21% year-over-year to -$2.8 million; the TTM value through Mar 2026 reached -$13.5 million, down 82.53%, while the annual FY2025 figure was -$14.4 million, 38.94% down from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 was -$2.8 million at Axogen, up from -$11.1 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at $541000.0 in Q4 2024 and troughed at -$11.7 million in Q1 2022.
  • A 5-year average of -$4.7 million and a median of -$4.7 million in 2023 define the central range for Net Income towards Common Stockholders.
  • On a YoY basis, Net Income towards Common Stockholders climbed as much as 124.78% in 2025 and fell as far as 2158.78% in 2025.
  • Year by year, Net Income towards Common Stockholders stood at -$5.2 million in 2022, then rose by 9.09% to -$4.7 million in 2023, then soared by 111.51% to $541000.0 in 2024, then plummeted by 2158.78% to -$11.1 million in 2025, then skyrocketed by 75.24% to -$2.8 million in 2026.
  • Business Quant data shows Net Income towards Common Stockholders for AXGN at -$2.8 million in Q1 2026, -$11.1 million in Q4 2025, and $474000.0 in Q3 2025.